Skip to main content
CDC Website

English

Hepatitis C Medications: A Review and Update for Patients

This internet file educates patients about hepatitis C treatment. It discusses the drugs approved for treatment of hepatitis C, why medications are used to treat the disease and how they are used, how likely it that the treatment will work, how the doctor monitors patients during treatment, side effects and how to cope with them, how patients can improve the chances of responding to treatment, why some patients take treatment and others do not, and where to get more information on the subject.

TB Elimination: Treatment of Latent Tuberculosis Infection: Maximizing Adherence

This information sheet discusses the need for individuals with latent TB infection (LTBI) to get treatment and prevent the progression of LTBI to TB disease. It emphasizes the importance of the health care provider communicating the value of LTBI treatment and of identifying barriers to adherence. The information sheet also lists strategies for maximizing adherence including collaborating with community agencies and partnering with local health departmetns and community based organizations that can provide needed resources.

TB Elimination: BCG Vaccine

This information sheet discusses the bacille Calmette-Guerin (BCG) vaccine for TB disease, which is used in many countries to prevent childhood tuberculous meningitis and miliary disease. It explains why the BCG is not generally recommended for use in the United States; suggests that the BCG should be considered under specific circumstances; and provides recommendations for when the BCG should be used with children and health care workers and contraindications when it should not be used, such as for immunosuppressed persons and pregnant women.

It's Time: Integrate Viral Hepatitis Into Your Work

This information sheet is an agenda for providers who are taking a two-day training program in which they learn to serve persons at high risk for viral hepatitis. This material lists the training objectives and provides training modules, including specific modules targeted for substance use programs. The training can be used in substance use settings, STD/public health settings, HIV/AIDS programs, and correctional settings, as well as used for providers from all four target settings.

Tuberculosis: Get the Facts

Using a question-and-answer format, this pamphlet provides general information about TB, including transmission, symptoms, and the difference between TB infection and disease. The pamphlet explains both a blood and skin test, the procedures that are followed if the test result is negative or positive, and treatment for both TB infection and TB disease.

Stepwise Approach for Detecting, Evaluating, and Treating Chronic Hepatitis B Virus Infection: Federal Bureau fo Prisons Clinical Practice Guidelines

The Federal Bureau of Prisons (BOP) Stepwise Approach for Detecting, Evaluating, and Treating Chronic Hepatitis B Virus Infection provides recommendations for the medical management of federal inmates with chronic hepatitis B, or who are otherwise at risk of infection. The treatment of chronic hepatitis B in pregnancy or with hepatocellular carcinoma is beyond the scope of this guideline. For a more in-depth discussion of vaccination strategies and management of blood and body fluid exposures, the reader should refer to the BOP Clinical Practice Guidelines for those topics.

What is TB? Video

The "What is TB?" video provides general information about TB disease and TB infection. The video is available in English, Tagalog, Spanish, and Vietnamese.

Hepatitis and Your Liver

This video contains general information on the liver and its function,and how hepatitis affects the liver. The transcript video is included. This video can only be viewed with Windows Media Player version 10 or Real One Player.

HCV Coinfection: Expanding Access Through the RWCA

This slide set discusses use of the Ryan White Care Act (RWCA) to provide treatment of hepatitis C coinfection in persons living with HIV. It presents an overview of viral hepatitis, the basics of hepatitis C compared with hepatitis A and B, acute and chronic infection, prevention, HCV treatment and side effects of treatment, treatment decisions,, barriers to treatment, and increasing access to treatment through the RWCA.